From the Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
D000881:Anthrax / Q000517:prevention & control*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001408:Bacillus anthracis; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D010406:Penicillins / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D013171:Spores, Bacterial
D000900:Anti-Bacterial Agents; D010406:Penicillins; D002939:Ciprofloxacin; D004318:Doxycycline